Perspectives in Drug Discovery and Design

Title Publication Date Language Citations
Partial Least Squares (PLS): Its strengths and limitations1993/12/01English4
Mycophenolate mofetil: Molecular mechanisms of action1994/08/01English2
Viral cysteine proteinases1996/12/01English1
Families and clans of cysteine peptidases1996/12/01English1
Dissimilarity-based compound selection techniques1996/12/01English1
Free energies of hydration for organic molecules from Monte Carlo simulations1995/12/01English1
A comparison of combinatorial library approaches for the study of opioid compounds1995/04/01English
The theory and practice of combinatorial chemistry1995/04/01English
Progress in the discovery of orally bioavailable inhibitors of HIV protease1995/07/01English
Parasite cysteine proteinases1996/12/01English
The cysteine protease cathepsin B in cancer1996/12/01English
Preface1996/12/01English
The effect of workstation technology on methods in drug design and discovery1993/12/01English
Seeing our way to drug design1993/12/01English
Assemblin, a herpes virus serine maturational proteinase and new molecular target for antivirals1995/07/01English
Proteases as therapeutic targets1995/07/01English
Topological modification of oligonucleotides for potential inhibition of gene expression1996/12/01English
Infection of oral mucosal cells by HIV-11996/12/01English
Small-molecule inhibitors of thrombin1994/04/01English
Some observations on classical QSAR1993/12/01English
HIV-1 infection of human peripheral blood, cord blood and tonsillar dendritic cells1996/12/01English
HIV infection of endothelial cells1996/12/01English
Computational combinatorial chemistry for de novo ligand design: Review and assessment1995/12/01English
SPROUT, HIPPO and CAESA: Tools for de novo structure generation and estimation of synthetic accessibility1995/12/01English
Thrombin receptors as drug discovery targets1994/04/01English
Cysteine proteases of parasites: A remarkable diversity of function1995/07/01English
Preface1996/12/01English
Structure-based drug design (SBDD): Every structure tells a story...1993/12/01English
Structural modifications toward improved antisense oligonucleotides1996/12/01English
Lymphocyte ion channels as a target for immunosuppression1994/08/01English